IDO1 and neoplasm: The frequency of IDO+ pDCs in the TDLN of mice was decreased in dose-dependent fashion that correlated with the observed decreases in tumor size (Figure 2C), with doses of indoximod higher than 287 μmol/kg/dose bid resulting in a significant decrease in the proportion of IDO+ pDC in the TDLN.